Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Giles

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Current Treatment Options in Cardiovascular Medicine|February 23, 2002
Cardiovascular Complications of Collagen Vascular DiseaseGary E. Sander, Thomas D. Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|November 10, 2005
Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndromeThomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|July 20, 2006
The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventionsGary E Sander, Thomas D Giles
Expert Opinion on Pharmacotherapy|March 10, 2015
Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertensionGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Potassium: a non-celebrity cationCaroline Roffidal-Blanco, Thomas D Giles
The American Journal of Geriatric Cardiology|July 15, 2005
Medical management of myocardial ischemiaGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2005
Treating stage 2 hypertensionThomas D Giles, Barry J Materson
Reviews in Cardiovascular Medicine|August 18, 2006
Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?Michael A Weber, Thomas D Giles
Current Hypertension Reports|August 10, 2007
Effects of thiazolidinediones on blood pressureThomas D Giles, Gary E Sander
American Journal of Hypertension|August 25, 2004
Effects of olmesartan medoxomil on systolic blood pressure and pulse pressure in the management of hypertensionThomas D Giles, Thomas D Robinson
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Current Treatment Options in Cardiovascular Medicine|February 23, 2002
Cardiovascular Complications of Collagen Vascular DiseaseGary E. Sander, Thomas D. Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|November 10, 2005
Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndromeThomas D Giles, Gary E Sander
The American Journal of Geriatric Cardiology|July 20, 2006
The endocannabinoid system and cardiovascular risk: pathophysiologic role and developing therapeutic interventionsGary E Sander, Thomas D Giles
Expert Opinion on Pharmacotherapy|March 10, 2015
Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertensionGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Potassium: a non-celebrity cationCaroline Roffidal-Blanco, Thomas D Giles
The American Journal of Geriatric Cardiology|July 15, 2005
Medical management of myocardial ischemiaGary E Sander, Thomas D Giles
Journal of Clinical Hypertension (Greenwich, Conn.)|August 17, 2005
Treating stage 2 hypertensionThomas D Giles, Barry J Materson
Reviews in Cardiovascular Medicine|August 18, 2006
Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?Michael A Weber, Thomas D Giles
Current Hypertension Reports|August 10, 2007
Effects of thiazolidinediones on blood pressureThomas D Giles, Gary E Sander
American Journal of Hypertension|August 25, 2004
Effects of olmesartan medoxomil on systolic blood pressure and pulse pressure in the management of hypertensionThomas D Giles, Thomas D Robinson
Pageof 15